Management of bronchiolitis in infants and children.
Viswanathan
M
M
King
V J
VJ
Bordley
C
C
Honeycutt
A A
AA
Wittenborn
J
J
Jackman
A M
AM
Sutton
S F
SF
Lohr
K N
KN
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics; D001988:Bronchiolitis / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D017408:Guidelines as Topic; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000069455:Palivizumab; D019141:Respiratory System Agents / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D019141:Respiratory System Agents; D000069455:Palivizumab